Abstract
Aims Endoscopic retrograde cholangiopancreatography (ERCP) with brush cytology is commonly used to obtain tissue diagnosis of suspected malignant pancreatobiliary strictures. We aimed to compare the sensitivity of two intraductal brush cytology devices in these patients. Methods We performed a randomized controlled trial in consecutive patients with suspected malignant, non-hilar biliary strictures who underwent ERCP with concomitant sphincterotomy. Patients were randomly assigned (1:1) to either the Infinity​ or the RX cytology​ brush. Histopathological results, cytopathology results or clinical and/or radiological follow-up were used as reference standard. Primary endpoint was sensitivity, defined as brush cytology specimen showing at least suspicion of malignancy (Bethesda≥4) in patients with malignant diagnosis. Secondary endpoints were diagnostic performance and adverse events. Interim analysis was conducted after 50% of the patients completed follow-up. Results We screened 172 patients and could randomize 56 patients to the Infinity​ brush (24 patients, 43%) or to the RX cytology​ brush (32 patients, 57%) between June 2016 and April 2020. Sensitivity of the Infinity​ brush and RX cytology​ brush were 50% and 45%, respectively. Diagnosis was confirmed by histopathology (n=24, 43%), cytopathology (n=26, 46%), and clinical or radiological follow up (n=6, 11%) and revealed malignancy in 52 patients (93%) and benign disease in 4 patients (7%). No differences in diagnostic performance or adverse events were observed. The study was ended prematurely because of futility. Conclusions The results of this study showed at the interim analysis that the sensitivity of the Infinity​ brush is not superior to RX cytology​ brush for diagnosing malignant pancreatobiliary strictures. Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Keywords